Multi-centre study of the antihypertensive effect of lisinopril (20 mg) and a fixed combination of lisinopril (20 mg) and hydrochlorothiazide (12.5 mg) once daily in mild to moderate essential hypertension

Drug Development Research

Volumn 34, Issue suppl. 2, 1995, Pages 20-23

  Camera, M I ^a   Waisman, G D ^a   Galarza, C R ^a   Alfie, J ^a   Arahabety, A ^a   Saggese, O ^a   Magi, M I ^a   Mayorga, L M ^a  

^a NONE   (Argentina)

Author keywords

Angiotensin converting enzyme inhibitor; Hypertension; Safety

Indexed keywords

HYDROCHLOROTHIAZIDE; LISINOPRIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; EPIGASTRIC PAIN; ESSENTIAL HYPERTENSION; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; PRURITUS; RANDOMIZED CONTROLLED TRIAL; VERTIGO;

EID: 0028912015     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)